Identification of novel, potent and selective GCN2 inhibitors as first-in-class anti-tumor agents

Identification of novel, potent and selective GCN2 inhibitors as first-in-class anti-tumor agents — Image 2 of 13

Identification of novel, potent and selective GCN2 inhibitors as first-in-class anti-tumor agents — Image 3 of 13

Identification of novel, potent and selective GCN2 inhibitors as first-in-class anti-tumor agents — Image 4 of 13

Identification of novel, potent and selective GCN2 inhibitors as first-in-class anti-tumor agents — Image 5 of 13

Identification of novel, potent and selective GCN2 inhibitors as first-in-class anti-tumor agents — Image 6 of 13

Identification of novel, potent and selective GCN2 inhibitors as first-in-class anti-tumor agents — Image 7 of 13

Identification of novel, potent and selective GCN2 inhibitors as first-in-class anti-tumor agents — Image 8 of 13

Identification of novel, potent and selective GCN2 inhibitors as first-in-class anti-tumor agents — Image 9 of 13

Identification of novel, potent and selective GCN2 inhibitors as first-in-class anti-tumor agents — Image 10 of 13

Identification of novel, potent and selective GCN2 inhibitors as first-in-class anti-tumor agents — Image 11 of 13

Identification of novel, potent and selective GCN2 inhibitors as first-in-class anti-tumor agents — Image 12 of 13

Identification of novel, potent and selective GCN2 inhibitors as first-in-class anti-tumor agents — Image 13 of 13

3D model · NIH 3D

Identification of novel, potent and selective GCN2 inhibitors as first-in-class anti-tumor agents

Platform: NIH 3D
Price: Free
License: CC-BY; Print, modify and use commercially — credit the author.
Formats: WRLX3DSTLGLB

8 Downloads
141 Views

Author:Max Schwiening

Published 2020-10-14

Description

PDB Classifiation: transferase/transferase inhibitor

Tags

inhibitor kinase transferase-transferase inhibitor complex gcn2 anti-tumor phaser hkl-2000 refmac unidentified baculovirus pdb_extract 3.24

More like this

Similar models

Crystal Structure of the Kinase domain of Human VEGFR2 with imidazo[1,2-b]pyridazine derivative

Crystal Structure of the Kinase domain of Human VEGFR2 with imidazo[1,2-b]pyridazine derivative

NIH 3D BStromer

Crystal Structure of human PARP-1 ART domain bound to inhibitor UKTT-15

Crystal Structure of human PARP-1 ART domain bound to inhibitor UKTT-15

NIH 3D velagapudiuk

Crystal structure of phosphorylated RET tyrosine kinase domain complexed with a pyrazolo[1,5-a]pyrimidine inhibitor

Crystal structure of phosphorylated RET tyrosine kinase domain complexed with a pyrazolo[1,5-a]pyrimidine inhibitor

NIH 3D bhinnata

Pig Brain GABA-AT inactivated by (E)-(1S,3S)-3-Amino-4-fluoromethylenyl-1-cyclopentanoic acid

Pig Brain GABA-AT inactivated by (E)-(1S,3S)-3-Amino-4-fluoromethylenyl-1-cyclopentanoic acid

NIH 3D taylorandthenerds

Identification and optimization of pyridazinones as potent and selective c-Met kinase inhibitors

Identification and optimization of pyridazinones as potent and selective c-Met kinase inhibitors

NIH 3D tachikoma

Crystal Structure of the Kinase domain of Human HER2 (erbB2).

Crystal Structure of the Kinase domain of Human HER2 (erbB2).

NIH 3D ddiwanji

Calcium-Dependent Protein Kinase 1 from Toxoplasma gondii (TgCDPK1) in complex with inhibitor UW1553

Calcium-Dependent Protein Kinase 1 from Toxoplasma gondii (TgCDPK1) in complex with inhibitor UW1553

Src kinase in complex with a sulfonamide inhibitor

Src kinase in complex with a sulfonamide inhibitor

NIH 3D James Tyrwhitt Drake

Inhibitor bound structure of the kinase domain of the murine receptor tyrosine kinase TYRO3 (Sky)

Inhibitor bound structure of the kinase domain of the murine receptor tyrosine kinase TYRO3 (Sky)

NIH 3D llparker

DLK in complex with inhibitor 2-((6-(3,3-difluoropyrrolidin-1-yl)-4-(1-(oxetan-3-yl)piperidin-4-yl)pyridin-2-yl)amino)isonicotinonitrile

DLK in complex with inhibitor 2-((6-(3,3-difluoropyrrolidin-1-yl)-4-(1-(oxetan-3-yl)piperidin-4-yl)pyridin-2-yl)amino)isonicotinonitrile

NIH 3D digitallab

Crystal structure of human Pim-1 kinase in complex with an imidazopyridazine inhibitor.

Crystal structure of human Pim-1 kinase in complex with an imidazopyridazine inhibitor.

NIH 3D James Tyrwhitt Drake

Crystal structure of human anaplastic lymphoma kinase in complex with acyliminobenzimidazole inhibitor 36

Crystal structure of human anaplastic lymphoma kinase in complex with acyliminobenzimidazole inhibitor 36

Names are used only to indicate the source of a result. Polyzon is not affiliated with the listed sites.